Kaizawa
Hiroyuki Kaizawa, Tsukuba-Shi JP
Patent application number | Description | Published |
---|---|---|
20080214543 | N-Phenyl-(2R,5S)Dimethylpiperazine Derivative - The present invention relates to a novel N-phenyl-(2R,5S)dimethylpiperazine derivatives useful as antiandrogenic agent which exhibits a sufficient prostate gland reducing effect as compared with conventional compounds and are excellent in oral activity. The compound of the present application is useful in preventing or treating prostate cancer, benign prostatic hyperplasia, and the like. The present invention also provides a novel intermediate useful in producing the compound of the present invention. | 09-04-2008 |
20100137584 | FUSED HETEROARYL DERIVATIVES - The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity. | 06-03-2010 |
20100137585 | FUSED HETEROARYL DERIVATIVES - The present invention provides a pharmaceutical composition which is useful as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent, and it provides a novel bicyclic or tricyclic fused heteroaryl derivative or a salt thereof which possesses an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity. | 06-03-2010 |
Hiroyuki Kaizawa, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20110319385 | QUINOXALINE COMPOUND | 12-29-2011 |
20120184521 | SUBSTITUTED AMIDE COMPOUND - A substituted amide compound is useful as an active ingredient of a pharmaceutical composition, in particular a pharmaceutical composition for treating diseases caused by lysophosphatidic acid (LPA). The compound is of a formula: | 07-19-2012 |
20130085134 | QUINOXALINE COMPOUND - Quinoxaline compounds of formula (I) have a PDE9-inhibiting action and are useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. | 04-04-2013 |
20130225553 | PYRAZOLOQUINOLINE COMPOUND - The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like, and thus, have found that a pyrazoloquinoline compound has a PDE9-inhibiting action, thereby completing the present invention. | 08-29-2013 |
20130231320 | SUBSTITUTED AMIDE COMPOUND - A substituted amide compound is useful as an active ingredient of a pharmaceutical composition, in particular a pharmaceutical composition for treating diseases caused by lysophosphatidic acid (LPA). The compound is of a formula: | 09-05-2013 |
20130296329 | QUINOXALINE COMPOUND - The present inventors have investigated a compound which has a PDE9-inhibitory action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like, and thus, have found that an imidazoquinoxaline compound or a triazoloquinoxaline compound has a PDE9-inhibitory action, thereby completing the present invention. | 11-07-2013 |
Satoshi Kaizawa, Machida JP
Patent application number | Description | Published |
---|---|---|
20100110543 | LAMINATED QUARTER WAVE PLATE - A laminated quarter wave plate includes: a first wave plate made of an optically uniaxial crystal material; and a second wave plate made of an optically uniaxial crystal material. In the laminated quarter wave plate, the first and second wave plates are disposed in this order from an entrance side of light so that the optical axes of the first and second wave plates intersect with each other at an angle of 90°, and a phase difference Γ | 05-06-2010 |